Frequent PTEN Loss and Differential HER2/PI3K Signaling Pathway Alterations in Salivary Duct Carcinoma: Implications for Targeted Therapy

Cancer - United States
doi 10.1002/cncr.31600
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

HER2 Signaling Modulates the Equilibrium Between Pro- And Antiangiogenic Factors via Distinct Pathways: Implications for HER2-targeted Antibody Therapy

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Interleukin-6 Mediates Resistance to PI3K-pathway–targeted Therapy in Lymphoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

PI3K/PTEN/Akt/mTOR Pathway Aberrations and Co-Incidence of Hormone Receptors and HER2 in 19,784 Diverse Solid Tumors.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Cancer Research
Cancer ResearchOncology
2008English

Zuo Jin Wan Reverses DDP Resistance in Gastric Cancer Through ROCK/PTEN/PI3K Signaling Pathway

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2018English

NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination

Journal of Immunology
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy